The Impact of CASP8 rs10931936 and rs1045485 Polymorphisms as well as the Haplotypes on Breast Cancer Risk: A Case-Control Study
- PMID: 31362911
- DOI: 10.1016/j.clbc.2019.02.011
The Impact of CASP8 rs10931936 and rs1045485 Polymorphisms as well as the Haplotypes on Breast Cancer Risk: A Case-Control Study
Abstract
Introduction: Single nucleotide polymorphisms account for most genetic predispositions to breast cancer in the general population. Because of the lack of studies concerning the 2 common polymorphisms in caspase 8 (CASP8), namely rs104548 and rs10931936 in Iranian population, we evaluated the association of these 2 polymorphisms and their haplotypes with breast cancer and molecular profile.
Materials and method: Blood samples were collected from 287 breast cancer patients and 490 controls. Genotyping of rs1045485 and rs10931936 was conducted using an amplification refractory mutation system and polymerase chain reaction restriction fragment length polymorphism, respectively. PHASE version 2 (Matthew Stephens) was used to estimate the frequencies of haplotypes. Statistical analysis was performed using SPSS 16.0 (SPSS Inc).
Results: Although hormone receptors and the molecular profile did not indicate any significant association with different genotypes (P > .05), patients with CC genotype of rs1045485 were more likely to have HER2-positive breast cancer than those with GG genotype (odds ratio [OR], 2.93; 95% confidence interval [CI], 1.0 4-8.26). In addition, CC genotype of D302H was associated with a decreased risk of breast cancer to 48% (OR, 0.52; 95% CI, 0.30-0.90) whereas no significant association was found between rs10931936 and breast cancer. Haplotype analysis indicated C-C haplotype is associated with the decreased risk of breast cancer (OR, 0.69; 95% CI, 0.52-0.91).
Conclusion: Our data showed a protective effect for CC genotype of rs1045485 variant and C-C haplotype of rs10931936-rs104548 in CASP8 in association with the decrease risk of breast cancer whereas rs10931936 showed no significant association. CASP8 rs1045485 polymorphism might be a candidate genetic marker to evaluate risk of breast cancer. However, further larger studies can confirm such findings.
Keywords: Association studies; Breast neoplasm; Genetic risk factors; Genetic variations; Haplotype analysis.
Copyright © 2019 Elsevier Inc. All rights reserved.
Similar articles
-
Genetic contribution of caspase-8 variants and haplotypes to breast cancer risk and prognosis: a case-control study in Iran.BMC Med Genomics. 2023 Apr 4;16(1):72. doi: 10.1186/s12920-023-01484-0. BMC Med Genomics. 2023. PMID: 37016353 Free PMC article.
-
HER2 Codon 655 (Ile/Val) Polymorphism and Breast Cancer in Austrian Women.Anticancer Res. 2015 Nov;35(11):5901-4. Anticancer Res. 2015. PMID: 26504013
-
Identification of Novel Breast Cancer Risk Loci.Cancer Res. 2017 Oct 1;77(19):5428-5437. doi: 10.1158/0008-5472.CAN-17-0992. Epub 2017 Aug 3. Cancer Res. 2017. PMID: 28775167
-
Impact of molecular subtypes classification concordance between preoperative core needle biopsy and surgical specimen on early breast cancer management: Single-institution experience and review of published literature.Eur J Surg Oncol. 2017 Apr;43(4):642-648. doi: 10.1016/j.ejso.2016.10.025. Epub 2016 Nov 17. Eur J Surg Oncol. 2017. PMID: 27889196 Review.
-
A systematic review of the relationship between polymorphic sites in the estrogen receptor-beta (ESR2) gene and breast cancer risk.Breast Cancer Res Treat. 2011 Feb;126(1):37-45. doi: 10.1007/s10549-010-0891-2. Breast Cancer Res Treat. 2011. PMID: 20390341
Cited by
-
Differences in the distribution of HER2-positive breast tumors according to ethnicity and genetic variants in ERBB2: a special focus on Asian and Latina women.Front Oncol. 2025 Jul 24;15:1635681. doi: 10.3389/fonc.2025.1635681. eCollection 2025. Front Oncol. 2025. PMID: 40777119 Free PMC article. Review.
-
Germline Non-CDKN2A Variants in Melanoma and Associated Hereditary Cancer Syndromes.Diseases. 2025 Jun 9;13(6):180. doi: 10.3390/diseases13060180. Diseases. 2025. PMID: 40558591 Free PMC article. Review.
-
Two tSNPs in BRIP1 are associated with breast cancer during TDT analysis.Mol Genet Genomic Med. 2021 Feb;9(2):e1578. doi: 10.1002/mgg3.1578. Epub 2021 Jan 5. Mol Genet Genomic Med. 2021. PMID: 33403820 Free PMC article.
-
Precision proteogenomics reveals pan-cancer impact of germline variants.Cell. 2025 May 1;188(9):2312-2335.e26. doi: 10.1016/j.cell.2025.03.026. Epub 2025 Apr 14. Cell. 2025. PMID: 40233739
-
Unveiling novel susceptibility genes and drug targets for basal cell carcinoma by a cross-tissue transcriptome-wide association study.Discov Oncol. 2025 Mar 10;16(1):288. doi: 10.1007/s12672-025-02019-y. Discov Oncol. 2025. PMID: 40063313 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous